These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4365093)

  • 21. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
    Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
    Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
    Shapiro IM; Luka J; Andersson-Anvret M; Klein G
    Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of murine C-type viruses. 3. Antigenic conversion and focus induction.
    Grundner G; Fenyö EM; Klein E
    Int J Cancer; 1974 Mar; 13(3):412-9. PubMed ID: 4362613
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology.
    Lenoir G; Tovey MG; Lavoue MF
    J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Nonoyama M
    Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybridization of Burkitt lymphoblastoid cells.
    Glaser R; O'Neill FJ
    Science; 1972 Jun; 176(4040):1245-7. PubMed ID: 4338252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface antigens and release of virus in hybrid cells produced by the fusion of A9 fibroblasts with Moloney Lymphoma cells.
    Fenyö EM; Grundner G; Klein G; Klein E; Harris H
    Exp Cell Res; 1971 Oct; 68(2):323-31. PubMed ID: 4108040
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
    Yamamoto K; Osato T
    Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoproliferative effect of Epstein-Barr virus on normal human lymphocytes in cultures.
    Gerber P; Whang-Peng J; Monroe JH
    Bibl Haematol; 1970; (36):739-50. PubMed ID: 4376394
    [No Abstract]   [Full Text] [Related]  

  • 32. [Induction of a viral expression by 5-bromodeoxyuridine (BUdR) and 5-iododeoxyuridine (IUdR), in cell lines derived from Burkitt's lymphoma and rhinopharyngeal cancers].
    Didier-Fichet ML; de Thé G
    C R Acad Hebd Seances Acad Sci D; 1972 Apr; 274(17):2549-52. PubMed ID: 4624837
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
    Moar MH; Siegert W; Klein G
    Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: In vitro induction of EBV early antigens in NPC epithelial tumour cells by IUDR or superinfection.
    Glaser R; Lenoir G; Ho JH; De Thé G
    Biomedicine; 1975 Dec; 23(10):468-9. PubMed ID: 177117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrids between human leukocytes and a mouse cell line: production and characterization.
    Miggiano V; Nabholz M; Bodmer W
    Wistar Inst Symp Monogr; 1969; 9():61-76. PubMed ID: 5408740
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression of the human cytomegalovirus genome in mouse cells and in human-mouse heterokaryons.
    Boldogh I; Gönczöl E; Gärtner L; Váczi G
    Arch Virol; 1977; 53(1-2):101-8. PubMed ID: 192177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
    Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
    Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and viral antigen formation by IUDR and TPA.
    Lau RY; Nonoyama M; Klein G
    Virology; 1981 Apr; 110(2):259-69. PubMed ID: 6261446
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromosome banding, isoenzyme studies and determination of Epstein-Barr virus DNA content on human Burkitt lymphoma/mouse hybrids.
    Spira J; Povey S; Wiener F; Klein G; Andersson-Anvret M
    Int J Cancer; 1977 Dec; 20(6):849-53. PubMed ID: 201572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.